Clinical Trial Update: Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting Phase 1/Phase 2 results for a Lestaurtinib–Cytarabine–Idarubicin regimen in younger patients with relapsed or refractory acute m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Idarubicin (idarubicin)
• Lestaurtinib (CEP-701) (Lestaurtinib)

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-12-20